Anbex Awarded Bid from Hong Kong’s Department of Health
April 4, 2024
St. George-based Anbex has been awarded a bid from Hong Kong’s Department of Health for the supply of 187,040, 130mg IOSAT tablets. Anbex had previously won a similar-sized award from Hong Kong in 2021 on the supply of their potassium iodide tablets. Anbex is currently bidding on the supply of IOSAT tablets to Mexico, Argentina, Brazil, and Saudi Arabia. Anbex contracts with St. George-based Deseret Labs to manufacture the tablets.
For more information, visit anbex.com.
Recent News
- Canyon Labs Launches Expanded Reprocessing Validation Services for Medical Devices
- Connecting with Life Sciences in Logan
- Halia Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
- Ratio Therapeutics Enters into Research Collaboration, License Agreement with RayzeBio to Advance a Novel Radiopharmaceutical Program
- Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
- Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
